Last reviewed · How we verify

NCT06626607: DADAD

Different Antihypertensive Drugs on Aortic Diseases

Completed Last updated 4 October 2024
What this trial tests

trial testing CCB use in Aortic Aneurysm in 704 participants. Completed in 30 September 2024.

Timeline
1 January 2017
Primary endpoint
30 May 2024
30 September 2024

Quick facts

Lead sponsorEighth Affiliated Hospital, Sun Yat-sen University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment704
Start date1 January 2017
Primary completion30 May 2024
Estimated completion30 September 2024

Drugs / interventions tested

Conditions studied

Sponsor

Eighth Affiliated Hospital, Sun Yat-sen University

Who can join

18 and older, any sex, with Aortic Aneurysm or Aortic Dissection. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this observational study is to learn about the effect of different hypotensive drugs on the prognosis of postoperative aortic patients. The main question it aims to answer is: Does different hypotensive drugs influence the prognosis of postoperative aortic patients? As participants already taking hypotensive drugs as part of their regular medical care, the investigators collect the participants' pre-operation medical record and post-operative follow-up record to evaluate the aorta condition.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Aortic Aneurysm

Currently open trials in the same condition.

Other Eighth Affiliated Hospital, Sun Yat-sen University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06626607.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing